FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Champix 0.5mg tablets (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Sigma Pharmaceuticals Plc) 11 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets (Imported (Canada)) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 500microgram tablets (Imported (Canada)) 11 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Waymade Healthcare Plc) 11 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Sigma Pharmaceuticals Plc) 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Waymade Healthcare Plc) 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 500microgram tablets 11 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets (Imported (Canada)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 125mg/200ml infusion bags (Fresenius Kabi Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Mawdsley-Brooks & Company Ltd) 25 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Pfizer Ltd) 25 tablet 1 x (11 tablets + 14 tablets) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Mawdsley-Brooks & Company Ltd) 11 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets and Varenicline 500microgram tablets 25 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets (Imported (Canada)) 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Pfizer Ltd) 56 tablet 2 x 28 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Sigma Pharmaceuticals Plc) 25 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets and Varenicline 500microgram tablets 53 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Pfizer Ltd) 11 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 125mg/200ml solution for injection bags 12 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Waymade Healthcare Plc) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) 53 tablet 1x(11+14tablets)+1x(28tablets) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 500microgram tablets (Imported (Canada)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Pfizer Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets and Varenicline 500microgram tablets (Imported (Canada)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium pantothenate 550mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Byooviz 2.3mg/0.23ml solution for injection vials (Biogen Idec Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules 50 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Solgar L-Arginine 500mg capsules (Solgar Vitamin and Herb) 50 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Byooviz 2.3mg/0.23ml solution for injection vials (Biogen Idec Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Solgar L-Arginine 500mg capsules (Solgar Vitamin and Herb) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cetylpyridinium chloride 1.28mg/g / Menthol 330micrograms/g pastilles sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Argipressin 20units/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amphotericin (liposomal) 100mg powder for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dinoprostone 10mg vaginal pessaries VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nedocromil 2mg/actuation inhaler CFC free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fenofibrate 200mg capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Isopropyl alcohol 70% liquid VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 1.5g chewable tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.3% eye drops 0.4ml unit dose preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levonelle 750microgram tablets (Schering Health Care Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ketek 400mg tablets (Aventis Pharma) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rheumox 300mg capsules (Goldshield Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
XMet Homidon powder (SHS International Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cozaar 25mg tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levonelle-2 750microgram tablets (Schering Health Care Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Grisovin 125mg tablets (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Resource Protein Extra liquid chocolate (Novartis Consumer Health UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Scholl metatarsal arch supports (SSL International Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sinequan 25mg capsules (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Penbritin 500mg powder for solution for injection vials (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme chroma 0 pale ivory (Brodie & Stone Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pregestimil LIPIL powder (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Resource Protein Extra liquid vanilla (Novartis Consumer Health UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Resource Protein Extra liquid apricot (Novartis Consumer Health UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sinequan 50mg capsules (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pepdite powder (SHS International Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lasix 5mg/5ml oral solution (Borg Medicare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Stelazine 2mg Spansules (Goldshield Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tritace 5mg capsules (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tritace 2.5mg capsules (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Resource Protein Extra liquid summer fruits (Novartis Consumer Health UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic 75 transdermal patches (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic 25 transdermal patches (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic 100 transdermal patches (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vivotif vaccine gastro-resistant capsules (Patientric Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orthovisc injection 2ml pre-filled syringes (Surgicraft) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Human Mixtard 20 Penfill 100units/ml suspension for injection 1.5ml cartridges (Novo Nordisk Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Human Mixtard 10 Penfill 100units/ml suspension for injection 1.5ml cartridges (Novo Nordisk Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Human Mixtard 50 Penfill 100units/ml suspension for injection 1.5ml cartridges (Novo Nordisk Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypurin Bovine Isophane 100units/ml suspension for injection 1.5ml cartridges (C P Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypurin Porcine Neutral 100units/ml suspension for injection 1.5ml cartridges (C P Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Human Mixtard 40 Penfill 100units/ml suspension for injection 1.5ml cartridges (Novo Nordisk Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lasilactone capsules (Borg Medicare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Colofac 50mg/5ml liquid (Solvay Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops (Nucare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hydergine 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vividrin 2% nasal spray (Nucare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nootropil 1.2g tablets (UCB (Pharma) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Asilone Windcheaters 100mg capsules (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strepsils Menthol and Eucalyptus lozenges (Crookes Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Monoparin 5,000units/1ml solution for injection ampoules (C P Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 22 of 86 Next End

This concept is not in any reference sets

Back to Start